Remove Advocacy Remove Epilepsy Remove Medical Evaluation
article thumbnail

DEA Pushes Marijuana Rescheduling Hearing To December: What Does This Mean For Cannabis?

Veriheal

Because the categorization of a controlled substance determines its availability and accessibility, the benefits of rescheduling are important to patients suffering from chronic pain, epilepsy, and other conditions. In August 2023, the HHS also crucially recommended to the DEA that cannabis be relisted from Schedule I to Schedule III.

DEA 97